Mr. Jason Dussault reports

INTELLISTAKE PROVIDES SCIENTIFIC OVERVIEW OF NANOAI'S NANOTECHNOLOGY DETECTION PROCESS, VALIDATED BY ONE OF THE WORLD'S LEADING SCIENTIFIC PUBLISHERS

Intellistake Technologies Corp. has provided the following overview of NanoAi Technologies' core detection process and the operational background of its founder, 12-year U.S. Navy SEAL veteran Craig Micklich, in connection with the company's previously announced proposed acquisition of NanoAi. Full transaction details are set out in the company's press release dated Aug. 4, 2026.

Peer reviewed in Scientific Reports (Nature Portfolio)

NanoAi's core sensing technology has been validated in a peer-reviewed study published in Scientific Reports, part of the Nature Portfolio, one of the world's leading scientific publishing families. Publication requires independent peer review, where qualified scientists with no involvement in the research evaluate the methodology, data and conclusions before a paper is accepted.

The study, titled "E.Co.Tech-electrochemical handheld breathalyzer COVID sensing technology" was published in March, 2022, and is freely accessible on-line. The research was conducted with the University of Texas at Dallas, Department of Biomedical Engineering, and Cleveland Clinic Abu Dhabi (IRB No. REC A-2020-043). Mr. Micklich, NanoAi's founder and chief executive officer, is a named co-author.

What the study found

The study evaluated whether a portable breath analyzer could screen for COVID-19 by detecting specific trace compounds in exhaled breath.

NanoAi's device uses a proprietary nanotechnology-based sensor to detect specific trace compounds at concentrations as low as 50 parts per billion.

The study tested the device on 84 subjects at Cleveland Clinic Abu Dhabi, who were being screened for COVID-19. The device did not miss a single positive case in the study environment. It achieved 100-per-cent sensitivity, 87.04-per-cent specificity and 91.36-per-cent overall accuracy, with statistical significance at p is less than 0.01. Every result was delivered using a portable, battery-powered, hand-held device.

Where this technology is being designed to operate

What the peer-reviewed study validated is NanoAi's core detection process: the underlying nanotechnology sensing science that identifies specific trace compounds in exhaled or ambient air at the nano level. The target compound in the published study was disease related, but the sensing process itself is not specific to disease detection. It is a method for identifying trace airborne signatures at concentrations measured in parts per billion, and that same process applies whether the compounds originate from a disease or from a security threat. Independent peer review of the process provides a proven scientific foundation for evaluating and developing additional applications, each of which may require further testing and validation before deployment.

That transition into defence and security applications is already under way through an established industry partnership. NanoAi holds a royalty-free licence agreement with Gentex Corp. as a development partner for the Ops-Core Railink headborne platform, announced by Gentex in June, 2025.

Gentex, headquartered in Carbondale, Pa., describes itself as a global leader in personal protection and situational awareness solutions for defence forces, emergency responders and industrial personnel. Its Ops-Core helmet systems are in service with United States and allied forces, and Gentex has supplied U.S. Special Operations Command since that command's activation in 1987.

Railink is Gentex's powered rail system for the Ops-Core helmet platform, designed to allow sensors, displays, augmented reality capability and wireless devices to draw power and share data directly from the helmet. NanoAi was named as one of 10 development partners granted royalty-free licences to build accessories on that platform, providing a defined integration path for NanoAi's sensing technology.

Craig Micklich: founder and CEO, NanoAi Technologies

Mr. Micklich is the founder, chairman and CEO of NanoAi Technologies. A 12-year U.S. Navy SEAL veteran, he identified the gap in real-time airborne threat detection from direct operational experience and built the platform to address it. He has led the technology and business since 2018, taking it from a bench-level experiment to a full-stack sensing platform with active defence and commercial partnerships.

Mr. Micklich is a service-connected disabled veteran and lifetime member of the UDT/SEAL community. After active duty, he mobilized with a small team to arrive among the first on site for Operation Toxic Gumbo following hurricane Katrina, helping rescue more than 800 people.

He held senior capital market roles including managing director at Deutsche Bank and senior vice-president at Morgan Stanley. He holds a BBA in finance and an MBA, and is the founder of Trident 183 LLC, a service-disabled veteran-owned small business. He is a co-author on the peer-reviewed research underlying the core technology. Under the definitive agreement between the company and NanoAi dated Aug. 3, 2026, Mr. Micklich and a second NanoAi nominee would join the Intellistake board upon closing.

Jason Dussault, chief executive officer of Intellistake, commented: "NanoAi's core detection science has been independently validated through a peer-reviewed study published in Nature's Scientific Reports. That is independent evidence that this technology has undergone serious scientific scrutiny, and that is something very exciting for us. I would encourage any investor to read the full study, which is available on-line. It speaks for itself. This is an exciting time for Intellistake as we work to complete the proposed acquisition of NanoAi."

Mr. Micklich, CEO of NanoAi Technologies, commented: "I have personally overseen extensive testing of this process across multiple environments. The sensor is built on a tiny chip. It is stackable, meaning you can layer multiple sensors to screen for several different threat categories at the same time, in a single device. That is what makes it different.

"The peer-reviewed study provided independent validation of what we had already demonstrated through extensive testing, and now the objective is to bring that capability to defence, law enforcement and critical infrastructure at scale and ultimately keep us safe from the unseen threats that plague our world."

Completion of the transaction remains subject to customary conditions, including completion of satisfactory due diligence (including verifying title to the intellectual property of NanoAi), completion of the audit of financial statements of NanoAi, the company maintaining a minimum cash balance of $2-million and no objection from the Canadian Securities Exchange. Closing is targeted within 60 days of the definitive agreement and subject to satisfaction of closing conditions therein.

About Intellistake Technologies Corp.

Intellistake is an artificial intelligence infrastructure company building enterprise-grade data intelligence solutions. Through its AI agent capabilities, validator operations, strategic digital asset participation and the development of modular fintech infrastructure, Intellistake is working to bridge the gap between emerging technology networks and real-world industry adoption across enterprise, defence and institutional markets.

We seek Safe Harbor.